Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe/fatal asthma.

Sally Wenzel1

  • 1National Jewish Medical and Research Center, Denver, CO 80206, USA. wenzels@njc.org

Chest
|March 12, 2003
PubMed
Summary
This summary is machine-generated.

Severe asthma remains poorly understood, with varying patient groups and complex underlying pathologies. Further research into genetic and environmental factors is crucial for developing effective treatments for this refractory condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to High IFN-γ and low SLPI mark severe asthma in mice and humans.

The Journal of clinical investigation·2025
Same author

Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study.

American journal of respiratory and critical care medicine·2025
Same author

Severe asthma exacerbations associated with unconventional natural gas development activity in area of concentrated development.

The Journal of asthma : official journal of the Association for the Care of Asthma·2025
Same author

Serum cAMP levels are increased in patients with asthma.

The Journal of clinical investigation·2025
Same author

SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis.

International journal of molecular sciences·2024
Same author

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.

The journal of allergy and clinical immunology. Global·2023
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
See all related articles

Area of Science:

  • Pulmonology
  • Clinical Medicine
  • Pathology

Background:

  • Severe asthma is a complex clinical condition often refractory to standard treatments.
  • Understanding the heterogeneity in disease development, including adult-onset severe asthma, is lacking.
  • The interplay of genetic and environmental factors in severe asthma pathogenesis is unclear.

Purpose of the Study:

  • To elucidate the clinical, physiological, and pathological characteristics of severe asthma.
  • To identify potential contributing factors to the development of severe asthma.
  • To highlight the challenges in treating severe asthma.

Main Methods:

  • The abstract does not specify the methods used.
  • Review of clinical, physiological, and pathological data in severe asthma patients.

Related Experiment Videos

  • Analysis of disease progression and patient subgroups.

    • Main Results:

    • Severe asthma presents with diverse clinical, physiological (e.g., air trapping, loss of elastic recoil), and pathological findings.
    • At least two distinct patient groups exist: those with lifelong severe asthma and those developing it in adulthood.
    • A significant portion of patients (at least one third) exhibit distinct pathologies beyond eosinophilic inflammation.

    Conclusions:

    • Severe asthma is a heterogeneous disease with poorly understood underlying mechanisms.
    • Current treatments are often inadequate due to the lack of comprehensive understanding.
    • Further research is needed to unravel the complexities of severe asthma for improved therapeutic strategies.